Atlas Trials

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

Clinical trial NCT02411786 · COMPLETED

Trial details

NCT number
NCT02411786
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2015-08-24
Primary completion
2019-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.